Recursion CEO launches pre-seed fund in response to NIH cuts

Altitude Labs, a biotechnology accelerator backed by Recursion Pharmaceuticals, on Wednesday said it is launching a new fund to give pre-seed grants to life sciences researchers and startups disrupted by cuts to federal funding provided through the National Institutes of Health.